1. Business

Global Ocular Implants Market-Projected to Reach $23.43 Billion by 2031

Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

 

 

“Global Ocular Implants Market-Projected to Reach $23.43 Billion by 2031”

 

Meticulous Research®, a leading global market research company, has released its latest report titled “Ocular Implants Market Size, Share, Forecast, & Trends Analysis by Type (Scleral, Stock, Orbital, Intraocular, Retinal, Corneal), Material (Silicone, Hydroxyapatite), Application (Prosthesis, Oculoplasty, Glaucoma Surgery), End User – Global Forecast to 2031.”

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5928

According to the new report, the global ocular implants market is poised to reach $23.43 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031. This robust growth is driven by an aging global population, increasing prevalence of eye diseases, the rise in minimally invasive surgical procedures, advancements in ocular implant technology, and escalating healthcare expenditures. Additionally, the surge in accident-related eye injuries further fuels the demand for ocular implants. However, market growth is tempered by challenges such as post-surgery complications, a shortage of skilled ophthalmic surgeons, stringent regulatory requirements, and high costs of implants.

Key Market Trends and Innovations

The ocular implants market is witnessing significant advancements and trends, including the development of biomaterial-based ocular implants, AI-driven 3D-printed prosthetic eyes, and drug-eluting implants. These innovations are expected to provide substantial growth opportunities for market participants.

Key Market Players

Leading companies in the ocular implants market include:

  • Alcon Inc. (Switzerland)
  • Bausch + Lomb Corporation (Canada)
  • Carl Zeiss AG (Germany)
  • Johnson & Johnson Vision Care, Inc. (U.S.)
  • STAAR Surgical Company (U.S.)
  • Morcher GmbH (Germany)
  • HOYA Corporation (Japan)
  • Glaukos Corporation (U.S.)
  • AbbVie Inc. (U.S.)
  • Vivani Medical Inc. (U.S.)

Market Segmentation and Future Outlook

The report segments the ocular implants market by type, material, application, end user, and geography.

  • Type: The market is bifurcated into non-functional implants (e.g., scleral shells, stock shells, custom-made prostheses) and functional implants (e.g., intraocular lenses, glaucoma implants, retinal implants, corneal implants). In 2024, the functional implant segment is expected to dominate the market, driven by a growing elderly population and increasing adoption of minimally invasive eye surgeries.
  • Material: The market is divided into inert materials (e.g., glass, silicone, methyl methacrylate) and biointegrated materials (e.g., hydroxyapatite, porous polyethylene, aluminum oxide). Inert materials are anticipated to hold the largest market share in 2024 due to their cost-effectiveness and high compatibility.
  • Application: Key applications include ocular prosthesis, glaucoma surgery, oculoplasty, and drug delivery. Glaucoma surgery is projected to account for the largest share of the market in 2024, supported by the rising incidence of glaucoma and enhanced accessibility to ocular implants.
  • End User: The market is categorized into hospitals, ophthalmic clinics, ambulatory surgery centers (ASCs), and other end users. Hospitals are expected to be the predominant end user segment in 2024, owing to their advanced medical facilities and a growing number of patients preferring hospital-based treatments.

Quick Buy @ https://www.meticulousresearch.com/Checkout/42330084

Geographical Insights

  • North America: Expected to hold the largest market share in 2024, driven by a high incidence of eye disorders, established presence of key market players, and advanced healthcare infrastructure.
  • Asia-Pacific: Forecasted to register the highest CAGR during the projection period, fueled by an increasing number of diabetic patients, rising geriatric population, and significant investments in healthcare infrastructure by regional governments.

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research